For the first time in our history, the American Cancer Society research budget is in jeopardy. As a direct result of COVID-19, deep cuts to our research funding could mean a generation of cancer research lost. We need your help now in these priority areas because...

WE ARE FIGHTING FOR A FUTURE WHERE

Health Equity &

Social Determinants of Health 

• Data shows that racial and ethnic minorities, members of the LGBTQ+ community and those with lower socioeconomic status have a disproportionate cancer burden

• ACS is slated to fund close to 60 grants in 2020 focused on health equity research and eliminating those disparities

• Grants are focused on how social determinants impact cancer incidence; how they impact access to care; how they impact outcomes of care; how they impact survivorship & quality of life

• Only 7% of NIH applicants are from underrepresented minority groups and less than 2% are Black Americans. 

• Through our Diversity Research Internship program we ensure college students of diverse backgrounds who are underrepresented in the cancer research field see medical research as a potential career opportunity.

Cancer Research & Preserving a Generation of Breakthroughs

• ACS invests in early-career investigators so they can establish their science to secure larger federal grant funding

• ACS invests in innovative and out of the box ideas across the cancer continuum

• More than $100 million of cancer research is at risk

• Failing to invest in research now means that we will have fewer preventative tools, fewer treatment options, lost progress towards a cure, and ultimately, more deaths from cancer in the future.

• Research takes years to come to fruition; a cancer breakthrough begins perhaps 10-20 years earlier. 

• A lack of available funding could deter young investigators with big ideas to leave the field for different careers. 

• If research is disrupted today, it means lives lost tomorrow.